Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Cyberattack Causes Delays for Millions of US Pharmacies
02/23/2024
The American Hospital Association advises health care organizations to disconnect and check systems after a cyberattack on national prescription processors, affecting millions of customers and causing disruptions in care delivery.
The American Hospital Association advises health care organizations to disconnect and check systems after a cyberattack on national prescription processors, affecting millions of customers and causing disruptions in care delivery.
The American Hospital...
02/23/2024
Pharmacy Learning Network
News
FDA Finds Concerns During Dr. Reddy’s, Kilitch Plant Inspections in India
02/23/2024
Two companies with multiple recalls in recent US Food and Drug Administration (FDA) Enforcement Reports received a combined 2 dozen FDA “observations” after October 2023 inspections of their India-based production plants.
Two companies with multiple recalls in recent US Food and Drug Administration (FDA) Enforcement Reports received a combined 2 dozen FDA “observations” after October 2023 inspections of their India-based production plants.
Two companies with multiple...
02/23/2024
Pharmacy Learning Network

Advertisement

News
Oral Contraceptives Recalled
02/23/2024
Teva Pharmaceuticals USA Inc. is recalling two lots of Nortrel oral contraceptive products because of tablet discoloration issues. According to the February 21, 2024, US Food and Drug Administration (FDA) Enforcement Report, tablets in...
Teva Pharmaceuticals USA Inc. is recalling two lots of Nortrel oral contraceptive products because of tablet discoloration issues. According to the February 21, 2024, US Food and Drug Administration (FDA) Enforcement Report, tablets in...
Teva Pharmaceuticals USA Inc. is...
02/23/2024
Pharmacy Learning Network
News
Hypertension Drug Recalled
02/22/2024
A single lot of hydralazine hydrochloride tablets distributed by Major Pharmaceuticals is under recall following an out-of-specification result obtained during routine stability testing for impurities. The recall appeared in the February 21,...
A single lot of hydralazine hydrochloride tablets distributed by Major Pharmaceuticals is under recall following an out-of-specification result obtained during routine stability testing for impurities. The recall appeared in the February 21,...
A single lot of hydralazine...
02/22/2024
Pharmacy Learning Network
News
Subpotent Injection Recalled
02/22/2024
IntegraDose Compounding Services is recalling 1299 syringes containing vasopressin in 0.9% sodium chloride that were distributed in Minnesota. According to the February 21, 2024, US Food and Drug Administration (FDA) Enforcement Report, the...
IntegraDose Compounding Services is recalling 1299 syringes containing vasopressin in 0.9% sodium chloride that were distributed in Minnesota. According to the February 21, 2024, US Food and Drug Administration (FDA) Enforcement Report, the...
IntegraDose Compounding Services...
02/22/2024
Pharmacy Learning Network

Advertisement

News
Behavior Health Medications Increase During COVID-19 Pandemic
02/22/2024
The use of behavioral health medications during the COVID-19 pandemic in the US remained stable overall, but there was a significant increase in the use of ADHD medications, according to a study published in JAMA Psychiatry.
The use of behavioral health medications during the COVID-19 pandemic in the US remained stable overall, but there was a significant increase in the use of ADHD medications, according to a study published in JAMA Psychiatry.
The use of behavioral health...
02/22/2024
Pharmacy Learning Network
News
Misprint Prompts Tablet Recall
02/15/2024
Dr. Reddy’s Laboratories Inc. is recalling more than 73,000 bottles of glimepiride tablets because of a misprint on the tablets. The recall was published in the February 14, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Dr. Reddy’s Laboratories Inc. is recalling more than 73,000 bottles of glimepiride tablets because of a misprint on the tablets. The recall was published in the February 14, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Dr. Reddy’s Laboratories Inc. is...
02/15/2024
Pharmacy Learning Network
News
Capsules Recalled for Unknown Impurity
02/15/2024
Amneal Pharmaceuticals of New York is recalling 858 bottles of phenoxybenzamine hydrochloride capsules because they are out of specification for an unknown impurity, according to the February 14, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New York is recalling 858 bottles of phenoxybenzamine hydrochloride capsules because they are out of specification for an unknown impurity, according to the February 14, 2024, US Food and Drug Administration (FDA)...
Amneal Pharmaceuticals of New...
02/15/2024
Pharmacy Learning Network

Advertisement

News
Class I Recall for Dozens of OTC Eye Drops
02/14/2024
Sterility concerns due to unsanitary manufacturing conditions have prompted the US Food and Drug Administration (FDA) to issue a Class I designation for a recall spanning 27 over-the-counter eye drops sold by various retailers throughout the...
Sterility concerns due to unsanitary manufacturing conditions have prompted the US Food and Drug Administration (FDA) to issue a Class I designation for a recall spanning 27 over-the-counter eye drops sold by various retailers throughout the...
Sterility concerns due to...
02/14/2024
Pharmacy Learning Network
News
Superpotency Concerns Prompt Recall of IV Hypotension Drug
02/09/2024
The US Food and Drug Administration (FDA) has issued a Class I designation for the recall of more than 41,000 bags of intravenous (IV) phenylephrine hydrochloride from Leiters Health, according to the February 7, 2024, FDA Enforcement Report....
The US Food and Drug Administration (FDA) has issued a Class I designation for the recall of more than 41,000 bags of intravenous (IV) phenylephrine hydrochloride from Leiters Health, according to the February 7, 2024, FDA Enforcement Report....
The US Food and Drug...
02/09/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use